His research consists of five chapters, including a systematic review, a scoping review, secondary data analysis for Indonesian National Health Insurance (NHI) data, Health-Related Quality of Life (HRQOL) survey, and cost-effectiveness analysis (CEA) of novel malaria treatment strategies. The systematic and scoping reviews aim to guide in evaluation of productivity losses in low- and middle-income countries (LMICs). These chapters were driven by the lack of global guidance in valuating productivity losses in these settings. Outputs from this chapter will contribute to the final cost-effectiveness analysis, which will allow the consideration of different methods of valuating productivity losses. Secondary data from NHI datasets will be conducted to evaluate the risk of haemolytic events and their associated cost to the current treatment strategy in Indonesia. Another novelty of this research is the data collection and analysis of HRQoL in malaria patients, something that has not previously been collected in vivax malaria patients. Lastly, a cost-effectiveness analysis will be conducted to evaluate the vivax malaria treatment strategies implemented in the EFFORT trial.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.